FDA Orange Book · active-ingredient family
Bisoprolol fumarate; hydrochlorothiazide
Bisoprolol fumarate; hydrochlorothiazide is approved as 1 brand and 15 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ZIAC · NDA 020186
1
Brand (NDA)
15
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ZIACRLD×3 | TEVA BRANDED PHARM | NDA 020186 | AB | Mar 26, 1993 |
Generic (ANDA) products (15)
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Bisoprolol fumarate; hydrochlorothiazide — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

